| Smouldering multiple sclerosis: the ‘real MS’ G Giovannoni, V Popescu, J Wuerfel, K Hellwig, E Iacobaeus, MB Jensen, ... Therapeutic advances in neurological disorders 15, 17562864211066751, 2022 | 186 | 2022 |
| Concordance and heritability of multiple sclerosis in Finland: study on a nationwide series of twins H Kuusisto, J Kaprio, E Kinnunen, T Luukkaala, M Koskenvuo, I Elovaara European journal of neurology 15 (10), 1106-1110, 2008 | 89 | 2008 |
| Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co‐twin study A Hietaharju, H Kuusisto, R Nieminen, K Vuolteenaho, I Elovaara, ... European journal of neurology 17 (2), 332-334, 2010 | 74 | 2010 |
| Intravenous immunoglobulins are a therapeutic option in the treatment of multiple sclerosis relapse I Elovaara, H Kuusisto, X Wu, S Rinta, P Dastidar, B Reipert Clinical neuropharmacology 34 (2), 84-89, 2011 | 51 | 2011 |
| Multiple sclerosis in Finland 2018—Data from the national register SM Laakso, M Viitala, H Kuusisto, T Sarasoja, P Hartikainen, S Atula, ... Acta Neurologica Scandinavica 140 (5), 303-311, 2019 | 49 | 2019 |
| Human herpes virus 6 and multiple sclerosis: a Finnish twin study H Kuusisto, H Hyöty, S Kares, E Kinnunen, I Elovaara Multiple Sclerosis Journal 14 (1), 54-58, 2008 | 41 | 2008 |
| Apoptosis-related molecules in blood in multiple sclerosis S Rinta, H Kuusisto, M Raunio, R Paalavuo, M Levula, T Lehtimäki, ... Journal of neuroimmunology 205 (1-2), 135-141, 2008 | 40 | 2008 |
| Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression N Pigard, I Elovaara, H Kuusisto, R Paalavuo, P Dastidar, K Zimmermann, ... Journal of neuroimmunology 209 (1-2), 114-120, 2009 | 35 | 2009 |
| Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study I Rauma, M Viitala, H Kuusisto, S Atula, JOT Sipilä, M Ryytty, ... Multiple sclerosis and related disorders 61, 103755, 2022 | 34 | 2022 |
| Gene expression profiles in Finnish twins with multiple sclerosis S Särkijärvi, H Kuusisto, R Paalavuo, M Levula, N Airla, T Lehtimäki, ... BMC medical genetics 7, 1-10, 2006 | 34 | 2006 |
| Asiakasturvallisuus sosiaali-ja terveysalalla T Kurki, V Jylhä, T Kekoni Helsinki: Gaudeamus, 2021 | 29 | 2021 |
| Medication adherence/persistence among patients with active multiple sclerosis in Finland S Lahdenperä, M Soilu‐Hänninen, HM Kuusisto, S Atula, J Junnila, ... Acta Neurologica Scandinavica 142 (6), 605-612, 2020 | 28 | 2020 |
| The STAR study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with … R Hupperts, L Ghazi-Visser, AM Silva, M Arvanitis, H Kuusisto, K Marhardt, ... Clinical therapeutics 36 (12), 1946-1957, 2014 | 28 | 2014 |
| Stroke thrombolysis given by emergency physicians cuts in-hospital delays significantly immediately after implementing a new treatment protocol I Heikkilä, H Kuusisto, A Stolberg, A Palomäki Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 24, 1-6, 2016 | 24 | 2016 |
| Ikääntyvien näkemyksiä sosiaali-ja terveydenhuollon sähköisistä palveluista J Mielonen, K Saranto, H Kuusisto, A Kemppi, UM Kinnunen Gerontologia 35 (1), 3-12, 2021 | 23 | 2021 |
| Fast protocol for treating acute ischemic stroke by emergency physicians I Heikkilä, H Kuusisto, M Holmberg, A Palomäki Annals of Emergency Medicine 73 (2), 105-112, 2019 | 22 | 2019 |
| NARP syndrome and adult‐onset generalised seizures T Keränen, H Kuusisto Epileptic disorders 8 (3), 200-203, 2006 | 21 | 2006 |
| Hospital training program increases awareness of Good Clinical Practice (GCP) H Kuusisto, M Virkki, E Wuolijoki, T Keränen Contemporary clinical trials 32 (3), 339-341, 2011 | 16 | 2011 |
| The retirement rate due to multiple sclerosis has decreased since 1995–A retrospective study in a Finnish central hospital T Heinonen, E Castrén, T Luukkaala, K Mäkinen, J Ruutiainen, ... Multiple sclerosis and related disorders 45, 102360, 2020 | 15 | 2020 |
| Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients I Rauma, T Mustonen, JM Seppä, M Ukkonen, M Männikkö, ... Journal of neurology, 1-12, 2022 | 13 | 2022 |
